中证医药优势成长50策略指数下跌1.1%,前十大权重包含药明康德等

金融界
02 Jul

金融界7月2日消息,上证指数高开震荡,中证医药优势成长50策略指数 (医药50策略,931698)下跌1.1%,报7317.81点,成交额188.23亿元。数据统计显示,中证医药优势成长50策略指数近一个月上涨2.28%,近三个月上涨1.96%,年至今上涨8.39%。据了解,中证医药优势成长50策略指数从医药行业上市公司证券中,采用成长、创新、低波、质量等因子进行选样和加权,旨在为投资者提供基于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10